Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Alcidion Group Limited ( (AU:ALC) ) has provided an update.
Alcidion Group Limited announced it will release its Q4 FY25 financial results and host an investor webcast on July 24, 2025. The webcast will feature discussions by the Group Managing Director and CEO, Kate Quirke, and CFO, Matthew Gepp, on the company’s operational and commercial highlights for the quarter. This announcement underscores Alcidion’s commitment to transparency with its stakeholders and its strategic focus on expanding its influence in the global healthcare market.
The most recent analyst rating on (AU:ALC) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on Alcidion Group Limited stock, see the AU:ALC Stock Forecast page.
More about Alcidion Group Limited
Alcidion Group Limited is a company focused on transforming healthcare through innovative technology solutions that enhance patient care efficiency and quality globally. The company offers a suite of software products and technical services, with its flagship product, Miya Precision, providing centralized dashboards, interoperability, communication, task management, and clinical decision support. Since its ASX listing in 2016, Alcidion has expanded its presence in the UK, Australia, and New Zealand, servicing over 400 hospitals and 87 healthcare organizations, with plans for further geographical expansion.
Average Trading Volume: 1,445,069
Technical Sentiment Signal: Buy
Current Market Cap: A$147.7M
See more data about ALC stock on TipRanks’ Stock Analysis page.